Chemoinformaics analysis of 2-DODECEN-1-YLSUCCINIC ANHYDRIDE
| Molecular Weight | 266.381 | nRot | 10 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 6 |
| Exact Molecular Weight | 266.188 | nRing | 1 |
| Solubility: LogS | -3.861 | nHRing | 1 |
| Solubility: LogP | 5.67 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 46.4626 |
| nHD | 0 | BPOL | 29.5554 |
| QED | 0.466 |
| Synth | 2.892 |
| Natural Product Likeliness | 0.981 |
| NR-PPAR-gamma | 0.311 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.011 |
| CACO-2 | -4.815 |
| MDCK | 0.0000293 |
| BBB | 0.192 |
| PPB | 0.993532 |
| VDSS | 2.724 |
| FU | 0.0205723 |
| CYP1A2-inh | 0.614 |
| CYP1A2-sub | 0.213 |
| CYP2c19-inh | 0.26 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.484 |
| CYP2c9-sub | 0.961 |
| CYP2d6-inh | 0.145 |
| CYP2d6-sub | 0.384 |
| CYP3a4-inh | 0.091 |
| CYP3a4-sub | 0.042 |
| CL | 7.998 |
| T12 | 0.714 |
| hERG | 0.005 |
| Ames | 0.015 |
| ROA | 0.097 |
| SkinSen | 0.766 |
| Carcinogencity | 0.607 |
| EI | 0.862 |
| Respiratory | 0.617 |
| NR-Aromatase | 0.469 |
| Antiviral | Yes |
| Prediction | 0.754301 |